DVAX (Dynavax Technologies Corporation) Stock Market Reviews

crown

search

Read and share opinions on DVAX (Dynavax Technologies Corporation) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stoc

DVAX

Dynavax Technologies Corporation

clarify Drug Manufacturers - Specialty & Generic

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Dynavax Technologies Corp (DVAX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Nov 6, 2025
Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates
Nov 5, 2025
Dynavax Technologies: Q3 Earnings Snapshot
Nov 5, 2025
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
Nov 5, 2025
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
Nov 5, 2025
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
Oct 22, 2025
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
Oct 21, 2025
Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook
Sep 2, 2025
Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference
Aug 27, 2025
Dynavax Says Shingles Vaccine Candidate Achieves Immune Response 'Similar' to Shingrix
Aug 21, 2025
Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile
Aug 21, 2025
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates
Aug 7, 2025
Dynavax Technologies: Q2 Earnings Snapshot
Aug 7, 2025

Reviews